Pay in 4 interest-free payments of $24.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
is angiotensin receptor neprilysin inhibitor being studied for use in combination with valsartan for heart failure
It modulates the coupling of Smo with its downstream effector by interacting with the Smo heptahelical domain (KD = 59 nM)
Development of Anilino-Maytansinoid ADCs that Efficiently Release Cytotoxic Metabolitesin Cancer Cells andInduce High Levels of Bystander Killing
selective and cell permeable BRPF1 bromodomain inhibitor with IC50 ~ 80 nM
PubMed Central PMCID: PMC3064743
R-GNE-140 - CAS# 2003234-63-5 size:2mg solid is angiotensin receptor neprilysin inhibitorR GNE 140, CAS No. 2003234 63 5, a novel potent lactate dehydrogenase (LDHA) inhibitor with IC50 3nM for LDHA and 5 nM for LDHB. In MIA PaCa 2 human pancreatic cells, LDHA inhibition rapidly affected global metabolism, although cell death only occurred after 2 d of continuous LDHA inhibition. Pancreatic cell lines that utilize oxidative phosphorylation (OXPHOS) rather than glycolysis were inherently resistant to GNE 140, but could be resensitized to
US$ 170.00
US$ 6800.00
US$ 274.50